Amphastar Pharmaceuticals, Inc.AMPH

Market cap
$1.2B
P/E ratio
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents68667266867493126156144152
Restricted cash------20000
Short-term investments--1331213102011370
Restricted Investments, Current--1--222222
Accounts receivable, net233327365245667989115136
Inventories82718064691119793104106154
Income Tax Refund And deposits00060000012
Prepaid expenses and other assets44310510778918
Total current assets198176184188220255280318378490534
Property, Plant and Equipment, Net138142153185210234260244238283297
Finance lease right-of-use assets-----110110
Operating lease right-of-use assets-----192027263247
Investment in unconsolidated affiliate---------1-
Goodwill and intangible assets, net434050454241413937613591
Long-term investments---------1511
Other assets45991011517212626
Deferred tax assets-----262522395371
Total assets3893904284555145876316727421,5131,577
Accounts payable and accrued liabilities---58877796908493157
Accrued payments for BAQSIMI---------126-
Income taxes payable338312195210
Current portion of long-term debt81156188122300
Operating Lease, Liability, Current-----333347
Total current liabilities636061671079011210495225174
Accrued Income Taxes, Noncurrent00110357767
Long-Term Debt and Lease Obligation363032413239347573590602
Operating Lease, Liability, Noncurrent-----161725243042
Other long-term liabilities-227991316152321
Total liabilities1089598117149159183226213873845
Preferred Stock, Value, Issued-----------
Common Stock, Value, Issued00000000000
Additional paid-in capital221248283314344367410422455486505
Retained earnings6360717667116118180272409569
Accumulated other comprehensive loss-2-2-5-2-4-5-4-7-9-8-9
Treasury stock01020517598122150190247333
Total equity----364428449446529639732
Total liabilities and stockholders' equity3893904284555145876316727421,5131,577